RACHAEL FRANKLIN: Open Payments
NPI 1336919968 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,643 in 110 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,643 · 2025 $2,643
Food & beverage: $2,474Education: $169
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $592 |
| Janssen Biotech, Inc. | 14 | $353 |
| Incyte Corporation | 8 | $298 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $233 |
| Galderma Laboratories, L.P. | 6 | $206 |
| Novartis Pharmaceuticals Corporation | 8 | $196 |
| Mallinckrodt Hospital Products Inc. | 3 | $89 |
| UCB, Inc. | 4 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
Products named: TREMFYA, RINVOQ, OPZELURA, NEMLUVIO, DUPIXENT, SKYRIZI, BLU-U, ACTHAR.
Industry payments across AL — which companies pay providers there.
